The role of miRNA and lncRNA in gastric cancer
Metrics: PDF 3060 views | HTML 3581 views | ?
Ning-Bo Hao1,*, Ya-Fei He2,*, Xiao-Qin Li3, Kai Wang4 and Rui-Ling Wang1
1Department of Gastroenterology, General Hospital of the PLA Rocket Force, Beijing, China
2Intensive Medical Center, 302 Hospital of PLA, Beijing, China
3Department of Ophthalmology, General Hospital of the PLA Rocket Force, Beijing, China
4New Era Stoke Care and Research Institute, General Hospital of the PLA Rocket Force, Beijing, China
*These authors contributed equally to this work
Rui-Ling Wang, email: firstname.lastname@example.org
Keywords: gastric cancer, miRNA, lncRNA
Received: April 03, 2017 Accepted: June 20, 2017 Published: July 12, 2017
Gastric cancer is one of the most common cancers and has the highest mortality rate worldwide. It is worthwhile to explore the mechanism of gastric cancer progression. An increasing number of studies have found that non-coding RNAs including miRNA and lncRNA play important roles in gastric cancer progression. This review summarized the role of ectopic miRNA in gastric cancer proliferation, growth, migration, invasion and apoptosis. Meantime, aberrantly expressed miRNA also received a great deal of attention as potential biomarker for gastric cancer diagnosis and therapy. Over the last decade, lncRNA was considered to regulate gastric cancer progression at the transcript and post-transcript level. At the transcript level, lncRNA induced gastric cancer progression by changing chromatin modification and mRNA stabilization to regulate mRNA and miRNA expression. Furthermore, lncRNA regulated gastric cancer progression by completely combining with miRNA to produce ceRNA or promote protein stabilization at the post-transcript level. Greater attention of miRNA and lncRNA in gastric cancer can provide new insight of mechanism of cancer development and may be acted as a new anticancer target.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.